APA (7th ed.) Citation

C, L., A, Z., M, B., L, D., E, C., & L, B. (2022). Skin advanced glycation end products as a diagnostic and monitoring tool among psoriatic patients: How the therapy helps reduce cardiovascular disease risk. International journal of dermatology, 61(5), 577. https://doi.org/10.1111/ijd.15851

Chicago Style (17th ed.) Citation

C, Lanna, Zangrilli A, Bavetta M, Diluvio L, Campione E, and Bianchi L. "Skin Advanced Glycation End Products as a Diagnostic and Monitoring Tool Among Psoriatic Patients: How the Therapy Helps Reduce Cardiovascular Disease Risk." International Journal of Dermatology 61, no. 5 (2022): 577. https://doi.org/10.1111/ijd.15851.

MLA (9th ed.) Citation

C, Lanna, et al. "Skin Advanced Glycation End Products as a Diagnostic and Monitoring Tool Among Psoriatic Patients: How the Therapy Helps Reduce Cardiovascular Disease Risk." International Journal of Dermatology, vol. 61, no. 5, 2022, p. 577, https://doi.org/10.1111/ijd.15851.